LONDON MARKET MIDDAY: Lacklustre moves but FTSE 250 outperforms on M&A Read More
TOP NEWS: Carlyle offers GBP958 million for asthma drug maker Vectura Read More
LONDON MARKET OPEN: Vectura and Mediclinic boost FTSE 250 amid M&A Read More
LONDON MARKET PRE-OPEN: Vectura and Spire Healthcare accept offers Read More
UK shareholder meetings calendar - next 7 days Read More
Hikma resumes asthma drug launch, Vectura pays special dividend Read More
BROKER RATINGS: Barclays and Goldman Sachs downgrade Hammerson Read More
Vectura shares rise on swing to profit, GBP115 million special payout Read More
UK earnings, trading statements calendar - next 7 days Read More
LONDON BROKER RATINGS SUMMARY: Deutsche Bank Ups British Land, Landsec Read More
Vectura Forecasts 2020 Earnings To Top Board Expectations Read More
UK EXECUTIVE CHANGE SUMMARY: Nutrition Firm Director Joins Tate & Lyle Read More
Vectura Says Glaxo Will Not Appeal Award In Ellipta Litigation Read More
LONDON MARKET CLOSE: Stocks Fall As Investors Sweat On Brexit Deal Read More
LONDON MARKET MIDDAY: FTSE 100 Rises As Crunch Brexit Talks Dent Pound Read More
UK WINNERS & LOSERS SUMMARY: US Generic Advair Ok Lifts Hikma, Vectura Read More
Hikma Pharmaceuticals Gets US FDA Approval For Generic Advair Diskus Read More
IN BRIEF: Tissue Regenix Adds Former Vectura COO To Board Read More
Vectura Inks Agreement To Support Kinaset Therapeutics For Asthma Drug Read More
